Measuring Health-Related Quality of Life in Adolescent Populations: An Empirical Comparison of the CHU9D and the PedsQLTM 4.0 Short Form 15
暂无分享,去创建一个
John Brazier | Julie Ratcliffe | Katherine Stevens | Gang Chen | Christine Mpundu-Kaambwa | J. Brazier | J. Ratcliffe | K. Stevens | Christine Mpundu-Kaambwa | K. D. Petersen | Karin Dam Petersen | Gang Chen
[1] Jacob Cohen,et al. The Equivalence of Weighted Kappa and the Intraclass Correlation Coefficient as Measures of Reliability , 1973 .
[2] Stephen J. Walters,et al. Quality of Life Outcomes in Clinical Trials and Health-Care Evaluation: A Practical Guide to Analysis and Interpretation , 2009 .
[3] L. Rajmil,et al. Socioeconomic determinants of health related quality of life in childhood and adolescence: results from a European study , 2006, Journal of Epidemiology and Community Health.
[4] G. Holmbeck,et al. Adolescent health psychology. , 2002, Journal of consulting and clinical psychology.
[5] A. Frisén,et al. Measuring health‐related quality of life in adolescence , 2007, Acta paediatrica.
[6] Katherine Stevens,et al. Valuation of the Child Health Utility 9D Index , 2012, PharmacoEconomics.
[7] Julie Ratcliffe,et al. A Review of the Development and Application of Generic Multi-Attribute Utility Instruments for Paediatric Populations , 2015, PharmacoEconomics.
[8] J. Brazier,et al. Valuing Child Health Utility 9D Health States with Young Adults: Insights from a Time Trade Off Study , 2015, Applied Health Economics and Health Policy.
[9] Julie Ratcliffe,et al. Measuring and valuing health benefits for economic evaluation in adolescence: an assessment of the practicality and validity of the child health utility 9D in the Australian adolescent population. , 2012, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[10] Stephen J. Walters,et al. Quality of life outcomes in clinical trials and health-care evaluation , 2009 .
[11] J. Ratcliffe,et al. Adolescent, parent and societal preferences and willingness to pay for meningococcal B vaccine: A Discrete Choice Experiment. , 2016, Vaccine.
[12] J. Varni,et al. The PedsQL™ as a pediatric patient-reported outcome: reliability and validity of the PedsQL™ Measurement Model in 25,000 children , 2005, Expert review of pharmacoeconomics & outcomes research.
[13] John Brazier,et al. An assessment of the construct validity of the CHU9D in the Australian adolescent general population , 2012, Quality of Life Research.
[14] Mark Carpenter,et al. The New Statistical Analysis of Data , 2000, Technometrics.
[15] Katherine Stevens,et al. Developing a descriptive system for a new preference-based measure of health-related quality of life for children , 2009, Quality of Life Research.
[16] J. Varni,et al. The PedsQL™: Reliability and Validity of the Short-Form Generic Core Scales and Asthma Module , 2005, Medical care.
[17] M. Drummond. Introducing economic and quality of life measurements into clinical studies , 2001, Annals of medicine.
[18] Joffre Swait,et al. Valuing the Child Health Utility 9D: Using profile case best worst scaling methods to develop a new adolescent specific scoring algorithm. , 2016, Social science & medicine.
[19] K. Stevens. Valuation of the Child Health Utility Index 9D (CHU9D) , 2010 .
[20] Katherine Stevens,et al. Assessing the performance of a new generic measure of health-related quality of life for children and refining it for use in health state valuation , 2011, Applied health economics and health policy.
[21] R. Keren,et al. Measuring Health Preferences for Use in Cost-Utility and Cost-Benefit Analyses of Interventions in Children , 2012, PharmacoEconomics.
[22] K. Stevens,et al. Working With Children to Develop Dimensions for a Preference-Based, Generic, Pediatric, Health-Related Quality-of-Life Measure , 2010, Qualitative health research.
[23] Alessio Zambon,et al. The Family Affluence Scale as a Measure of National Wealth: Validation of an Adolescent Self-Report Measure , 2006 .
[24] S. Kleinert. Adolescent health: an opportunity not to be missed , 2007, The Lancet.
[25] J. Brazier,et al. Whose values in health? An empirical comparison of the application of adolescent and adult values for the CHU-9D and AQOL-6D in the Australian adolescent general population. , 2012, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[26] John Brazier,et al. Assessing the Health-Related Quality of Life of Australian Adolescents: An Empirical Comparison of the Child Health Utility 9D and EQ-5D-Y Instruments. , 2015, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[27] Julie Ratcliffe,et al. Mapping CHU9D Utility Scores from the PedsQLTM 4.0 SF-15 , 2017, PharmacoEconomics.
[28] C. Carswell. Measuring and Valuing Health Benefits for Economic Valuation , 2007, PharmacoEconomics.
[29] R. Viney,et al. Disinvestment and Value-Based Purchasing Strategies for Pharmaceuticals: An International Review , 2015, PharmacoEconomics.